DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
13F holders, Q1 2022
Institutional positions in DBV Technologies S.A. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −10 vs. Q4 2021
- Shares held
- 20.4M
- −951.5K (−4.5%) vs. Q4 2021
- Total value
- $32.9M
- −$1.81M (−5.2%) vs. Q4 2021
- New holders
- 3
- 4 more added
- Sold out
- 13
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $345.7M |
| Q1 2026 | 71 | $433.6M |
| Q4 2025 | 52 | $302.1M |
| Q3 2025 | 33 | $65.2M |
| Q2 2025 | 29 | $66.2M |
| Q1 2025 | 16 | $16.8M |
| Q4 2024 | 18 | $8.46M |
| Q3 2024 | 24 | $11.3M |
| Q2 2024 | 30 | $13.7M |
| Q1 2024 | 33 | $28.3M |
| Q4 2023 | 40 | $35.9M |
| Q3 2023 | 38 | $60.4M |
| Q2 2023 | 36 | $87.4M |
| Q1 2023 | 34 | $71.3M |
| Q4 2022 | 38 | $68.0M |
| Q3 2022 | 36 | $61.1M |
| Q2 2022 | 38 | $66.8M |
| Q1 2022 | 31 | $32.9M |
| Q4 2021 | 41 | $34.7M |
| Q3 2021 | 51 | $179.8M |
| Q2 2021 | 48 | $201.5M |
| Q1 2021 | 44 | $197.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding DBV Technologies S.A.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 50 | $0 | 0.00% | −500−90.9% | Reduced |
| JPMorgan Chase & Co | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 75 | $0 | 0.00% | +14+23.0% | Added |
| TCI Wealth Advisors, Inc. | 20 | $0 | 0.00% | 00.0% | Unchanged |
| Mark Sheptoff Financial Planning, LLC | 300 | $0 | 0.00% | 00.0% | Unchanged |
| Annapolis Financial Services, LLC | 270 | $0 | 0.00% | 00.0% | Unchanged |
| Exane Derivatives | 101 | $161 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 776 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 855 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,730 | $3.00K | 0.00% | −930−35.0% | Reduced |
| Wells Fargo & Company | 1,861 | $3.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 3,100 | $4.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 4,255 | $6.76K | 0.00% | 00.0% | Unchanged |
| Heritage Wealth Advisors | 6,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,957 | $13.0K | 0.00% | +7,957 | New |
| Goldman Sachs Group Inc | 14,400 | $23.0K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 14,713 | $23.0K | 0.00% | +14,713 | New |
| Personal Cfo Solutions, LLC | 16,088 | $26.0K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 22,116 | $35.0K | 0.00% | +22,116 | New |
| Optiver Holding B.V. | 22,472 | $36.0K | 0.00% | −568,815−96.2% | Reduced |
| Geode Capital Management, LLC | 23,666 | $37.0K | 0.00% | 00.0% | Unchanged |
| Janney Montgomery Scott LLC | 29,700 | $47.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 32,861 | $52.0K | 0.00% | 00.0% | Unchanged |
| Cowen and Company, LLC | 160,764 | $256.0K | 0.03% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 370,950 | $590.0K | 0.28% | 00.0% | Unchanged |
| Morgan Stanley | 560,121 | $890.0K | 0.00% | −326,953−36.9% | Reduced |
| Ikarian Capital, LLC | 316,939 | $1.05M | 0.32% | +6,829+2.2% | Added |
| BlackRock Inc. | 687,341 | $1.09M | 0.00% | +97,412+16.5% | Added |
| Ameriprise Financial Inc | 1,305,392 | $2.08M | 0.00% | +28,018+2.2% | Added |
| Boxer Capital, LLC | 2,134,598 | $3.39M | 0.17% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 14,614,264 | $23.2M | 0.13% | 00.0% | Unchanged |
| Credit Suisse AG | 0 | $0 | 0.00% | −77,067−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −53,242−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −26,663−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −25,229−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,507−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −1,666−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −1,446−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −1,470−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −355−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −428−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −74−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −196−100.0% | Sold out |